Monthly Round-Up of What to Read on Pharma Law and Policy
Bill of Health
NOVEMBER 17, 2022
Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016. Limitations on the Capability of the FDA to Advise. Medicaid Spending on Antiretrovirals from 2007-2019. A full posting of abstracts/summaries of these articles may be found on our? JAMA Intern Med. 2022 Oct 3:e224226.
Let's personalize your content